Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.

Lee JW, Zhang Y, Eoh KJ, Sharma R, Sanmamed MF, Wu J, Choi J, Park HS, Iwasaki A, Kaftan E, Chen L, Papadimitrakopoulou V, Herbst RS, Koo JS.

J Thorac Oncol. 2019 Jun;14(6):1046-1060. doi: 10.1016/j.jtho.2019.02.004. Epub 2019 Feb 13.

2.

Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck.

Lee JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, Yang DH, Zhu F, Mehra R, Sharma R, Gaffney SG, Perry EB, Townsend JP, Serebriiskii IG, Golemis EA, Issaeva N, Yarbrough WG, Koo JS, Burtness B.

Clin Cancer Res. 2019 Jun 1;25(11):3430-3442. doi: 10.1158/1078-0432.CCR-18-0440. Epub 2019 Feb 12.

3.

Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' Exons.

Eoh KJ, Park HS, Park JS, Lee ST, Han JW, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

Anticancer Res. 2018 Dec;38(12):6947-6953. doi: 10.21873/anticanres.13073.

PMID:
30504414
4.

Expression levels of the long noncoding RNA steroid receptor activator promote cell proliferation and invasion and predict patient prognosis in human cervical cancer.

Kim HJ, Kim LK, Lee SH, Park SA, Eoh KJ, Kim YT.

Oncol Lett. 2018 Oct;16(4):5410-5418. doi: 10.3892/ol.2018.9265. Epub 2018 Aug 3.

5.

Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.

Eoh KJ, Lee YJ, Kim HS, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

Surg Oncol. 2018 Sep;27(3):514-519. doi: 10.1016/j.suronc.2018.07.001. Epub 2018 Jul 2.

PMID:
30217312
6.

Periumbilical infiltration of lidocaine with epinephrine for postoperative pain reduction in single-port laparoscopic adnexal surgery.

Eoh KJ, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

J Obstet Gynaecol. 2018 Nov;38(8):1135-1139. doi: 10.1080/01443615.2018.1455079. Epub 2018 Sep 12.

PMID:
30207501
7.

Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas.

Kim YN, Eoh KJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Obstet Gynecol Sci. 2018 Jul;61(4):509-519. doi: 10.5468/ogs.2018.61.4.509. Epub 2018 Jun 18.

8.

Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study.

Kim M, Suh DH, Park JY, Paik ES, Lee S, Eoh KJ, Nam JH, Lee YY, Kim JW, Kim S.

J Gynecol Oncol. 2018 Jul;29(4):e60. doi: 10.3802/jgo.2018.29.e60. Epub 2018 Apr 13.

9.

In-bag power morcellation technique in single-port laparoscopic myomectomy.

Won YB, Lee HJ, Eoh KJ, Chung YS, Lee YJ, Park SH, Kim JW, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

Obstet Gynecol Sci. 2018 Mar;61(2):267-273. doi: 10.5468/ogs.2018.61.2.267. Epub 2018 Feb 2.

10.

MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.

Eoh KJ, Lee SH, Kim HJ, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

Biochem Biophys Res Commun. 2018 Mar 4;497(2):513-520. doi: 10.1016/j.bbrc.2018.02.062. Epub 2018 Feb 13.

PMID:
29452092
11.

Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer.

Yim GW, Eoh KJ, Chung YS, Kim SW, Kim S, Nam EJ, Lee JY, Kim YT.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):823-831. doi: 10.1016/j.jmig.2017.12.009. Epub 2017 Dec 26.

PMID:
29287717
12.

Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer.

Eoh KJ, Kim HJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Oncotarget. 2017 Sep 16;8(48):84396-84402. doi: 10.18632/oncotarget.21041. eCollection 2017 Oct 13.

13.
14.

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.

Eoh KJ, Chung YS, Lee SH, Park SA, Kim HJ, Yang W, Lee IO, Lee JY, Cho H, Chay DB, Kim S, Kim SW, Kim JH, Kim YT, Nam EJ.

Cancer Res Treat. 2018 Jul;50(3):956-963. doi: 10.4143/crt.2017.181. Epub 2017 Oct 17.

15.

Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas.

Eoh KJ, Kim HJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Oncotarget. 2017 Aug 1;8(41):70579-70585. doi: 10.18632/oncotarget.19771. eCollection 2017 Sep 19.

16.

Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.

Eoh KJ, Paek J, Kim SW, Kim HJ, Lee HY, Lee SK, Kim YT.

Oncol Rep. 2017 Dec;38(6):3481-3488. doi: 10.3892/or.2017.6023. Epub 2017 Oct 11.

17.

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2.

Eoh KJ, Kim JE, Park HS, Lee ST, Park JS, Han JW, Lee JY, Kim S, Kim SW, Kim JH, Kim YT, Nam EJ.

Cancer Res Treat. 2018 Jul;50(3):917-925. doi: 10.4143/crt.2017.220. Epub 2017 Sep 27.

18.

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.

Eoh KJ, Yoon JW, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

BMC Cancer. 2017 Jul 12;17(1):481. doi: 10.1186/s12885-017-3476-1.

19.

The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.

Eoh KJ, Yoon JW, Lee I, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

J Surg Oncol. 2017 Sep;116(3):329-336. doi: 10.1002/jso.24669. Epub 2017 May 22.

PMID:
28542980
20.

Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy.

Kim JS, Lee IO, Eoh KJ, Chung YS, Lee I, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

Obstet Gynecol Sci. 2017 Mar;60(2):178-186. doi: 10.5468/ogs.2017.60.2.178. Epub 2017 Mar 16.

22.

A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution.

Nam SM, Kim JW, Eoh KJ, Kim HM, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Obstet Gynecol Sci. 2017 Jan;60(1):39-45. doi: 10.5468/ogs.2017.60.1.39. Epub 2017 Jan 19.

23.

BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients.

Eoh KJ, Park JS, Park HS, Lee ST, Han J, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ.

Gynecol Oncol. 2017 Apr;145(1):137-141. doi: 10.1016/j.ygyno.2017.01.026. Epub 2017 Feb 1.

PMID:
28159408
24.

Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.

Eoh KJ, Lee JY, Yoon JW, Nam EJ, Kim S, Kim SW, Kim YT.

Oncotarget. 2017 Jun 6;8(23):37807-37816. doi: 10.18632/oncotarget.13696.

25.

The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.

Kim HJ, Eoh KJ, Kim LK, Nam EJ, Yoon SO, Kim KH, Lee JK, Kim SW, Kim YT.

Oncotarget. 2016 Dec 13;7(50):83001-83016. doi: 10.18632/oncotarget.12863.

26.

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients.

Eoh KJ, Park HS, Park JS, Lee ST, Han J, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ.

Cancer Res Treat. 2017 Apr;49(2):408-415. doi: 10.4143/crt.2016.135. Epub 2016 Jul 27.

27.

Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial Ovarian Carcinoma.

Yim GW, Eoh KJ, Kim SW, Nam EJ, Kim YT.

Nutr Cancer. 2016 Jul;68(5):772-9. doi: 10.1080/01635581.2016.1159702. Epub 2016 Apr 4.

PMID:
27044606
28.

Role of surgical therapy in the management of gestational trophoblastic neoplasia.

Eoh KJ, Chung YS, Yim GW, Nam EJ, Kim S, Kim SW, Kim YT.

Obstet Gynecol Sci. 2015 Jul;58(4):277-83. doi: 10.5468/ogs.2015.58.4.277. Epub 2015 Jul 16.

Supplemental Content

Support Center